Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma

Alina West, Raul C. Ribeiro, Jesse Jenkins, Carlos Rodriguez-Galindo, Bonald C. Figueiredo, Richard Kriwacki, Gerard P. Zambetti

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Hotspot mutations in the p53 tumor suppressor gene result in the disruption of DNA contact points or alter the overall structure of the protein to prevent DNA binding. When inherited, hotspot mutants are associated with Li-Fraumeni syndrome (LFS), a familial cancer predisposition. One of the most common hotspot mutations occurs at codon 175, resulting in an arginine to histidine substitution. We have identified a novel germ line variant of the 175 mutant (Arg to Leu; R175L) in a pediatric patient who developed adrenal cortical carcinoma. Surprisingly, the family is not tumor prone or associated with LFS. In vitro, the R175L mutant displayed an attenuated tumor suppressor activity in the regulation of transcription, colony formation, and apoptosis when compared with wild-type p53 and the R175H mutant. These findings suggest that p53-R175L retains sufficient activity to suppress LFS, but not adrenal cortical carcinoma. Therefore, not all hotspot mutants are functionally equivalent and the biochemical nature of the mutant may significantly influence clinical outcome. The implications of these results for genetic counseling are discussed.

Original languageEnglish (US)
Pages (from-to)5056-5062
Number of pages7
JournalCancer Research
Volume66
Issue number10
DOIs
StatePublished - May 15 2006

Fingerprint

Li-Fraumeni Syndrome
Adrenocortical Carcinoma
Germ Cells
Pediatrics
Neoplasms
Mutation
DNA
Genetic Counseling
Tumor Suppressor Genes
Histidine
Codon
Arginine
Apoptosis
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

West, A., Ribeiro, R. C., Jenkins, J., Rodriguez-Galindo, C., Figueiredo, B. C., Kriwacki, R., & Zambetti, G. P. (2006). Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma. Cancer Research, 66(10), 5056-5062. https://doi.org/10.1158/0008-5472.CAN-05-4580

Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma. / West, Alina; Ribeiro, Raul C.; Jenkins, Jesse; Rodriguez-Galindo, Carlos; Figueiredo, Bonald C.; Kriwacki, Richard; Zambetti, Gerard P.

In: Cancer Research, Vol. 66, No. 10, 15.05.2006, p. 5056-5062.

Research output: Contribution to journalArticle

West, A, Ribeiro, RC, Jenkins, J, Rodriguez-Galindo, C, Figueiredo, BC, Kriwacki, R & Zambetti, GP 2006, 'Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma', Cancer Research, vol. 66, no. 10, pp. 5056-5062. https://doi.org/10.1158/0008-5472.CAN-05-4580
West, Alina ; Ribeiro, Raul C. ; Jenkins, Jesse ; Rodriguez-Galindo, Carlos ; Figueiredo, Bonald C. ; Kriwacki, Richard ; Zambetti, Gerard P. / Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma. In: Cancer Research. 2006 ; Vol. 66, No. 10. pp. 5056-5062.
@article{c27c845763154caab1693628ec9a2ce2,
title = "Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma",
abstract = "Hotspot mutations in the p53 tumor suppressor gene result in the disruption of DNA contact points or alter the overall structure of the protein to prevent DNA binding. When inherited, hotspot mutants are associated with Li-Fraumeni syndrome (LFS), a familial cancer predisposition. One of the most common hotspot mutations occurs at codon 175, resulting in an arginine to histidine substitution. We have identified a novel germ line variant of the 175 mutant (Arg to Leu; R175L) in a pediatric patient who developed adrenal cortical carcinoma. Surprisingly, the family is not tumor prone or associated with LFS. In vitro, the R175L mutant displayed an attenuated tumor suppressor activity in the regulation of transcription, colony formation, and apoptosis when compared with wild-type p53 and the R175H mutant. These findings suggest that p53-R175L retains sufficient activity to suppress LFS, but not adrenal cortical carcinoma. Therefore, not all hotspot mutants are functionally equivalent and the biochemical nature of the mutant may significantly influence clinical outcome. The implications of these results for genetic counseling are discussed.",
author = "Alina West and Ribeiro, {Raul C.} and Jesse Jenkins and Carlos Rodriguez-Galindo and Figueiredo, {Bonald C.} and Richard Kriwacki and Zambetti, {Gerard P.}",
year = "2006",
month = "5",
day = "15",
doi = "10.1158/0008-5472.CAN-05-4580",
language = "English (US)",
volume = "66",
pages = "5056--5062",
journal = "Cancer Research",
issn = "0008-5472",
number = "10",

}

TY - JOUR

T1 - Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma

AU - West, Alina

AU - Ribeiro, Raul C.

AU - Jenkins, Jesse

AU - Rodriguez-Galindo, Carlos

AU - Figueiredo, Bonald C.

AU - Kriwacki, Richard

AU - Zambetti, Gerard P.

PY - 2006/5/15

Y1 - 2006/5/15

N2 - Hotspot mutations in the p53 tumor suppressor gene result in the disruption of DNA contact points or alter the overall structure of the protein to prevent DNA binding. When inherited, hotspot mutants are associated with Li-Fraumeni syndrome (LFS), a familial cancer predisposition. One of the most common hotspot mutations occurs at codon 175, resulting in an arginine to histidine substitution. We have identified a novel germ line variant of the 175 mutant (Arg to Leu; R175L) in a pediatric patient who developed adrenal cortical carcinoma. Surprisingly, the family is not tumor prone or associated with LFS. In vitro, the R175L mutant displayed an attenuated tumor suppressor activity in the regulation of transcription, colony formation, and apoptosis when compared with wild-type p53 and the R175H mutant. These findings suggest that p53-R175L retains sufficient activity to suppress LFS, but not adrenal cortical carcinoma. Therefore, not all hotspot mutants are functionally equivalent and the biochemical nature of the mutant may significantly influence clinical outcome. The implications of these results for genetic counseling are discussed.

AB - Hotspot mutations in the p53 tumor suppressor gene result in the disruption of DNA contact points or alter the overall structure of the protein to prevent DNA binding. When inherited, hotspot mutants are associated with Li-Fraumeni syndrome (LFS), a familial cancer predisposition. One of the most common hotspot mutations occurs at codon 175, resulting in an arginine to histidine substitution. We have identified a novel germ line variant of the 175 mutant (Arg to Leu; R175L) in a pediatric patient who developed adrenal cortical carcinoma. Surprisingly, the family is not tumor prone or associated with LFS. In vitro, the R175L mutant displayed an attenuated tumor suppressor activity in the regulation of transcription, colony formation, and apoptosis when compared with wild-type p53 and the R175H mutant. These findings suggest that p53-R175L retains sufficient activity to suppress LFS, but not adrenal cortical carcinoma. Therefore, not all hotspot mutants are functionally equivalent and the biochemical nature of the mutant may significantly influence clinical outcome. The implications of these results for genetic counseling are discussed.

UR - http://www.scopus.com/inward/record.url?scp=33744931918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744931918&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-4580

DO - 10.1158/0008-5472.CAN-05-4580

M3 - Article

C2 - 16707427

AN - SCOPUS:33744931918

VL - 66

SP - 5056

EP - 5062

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 10

ER -